PIMECROLIMUS
UNII 7KYV510875

Substance Identification & Data

This profile provides standardized clinical and technical data for Pimecrolimus, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7KYV510875.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 137071-32-0 and the RxNorm Concept ID (RxCUI) 321952. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7KYV510875

CAS Registry Number

137071-32-0

RxNorm Concept ID

321952

Detailed Substance Profile

Preferred Name

PIMECROLIMUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

7KYV510875

The specific atomic composition represented as a molecular structure string.

InChIKey

C43H68ClNO11

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KASDHRXLYQOAKZ-XDSKOBMDSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C47671

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

6509979

Unique identification number in the NCBI database of chemical substances.

INN ID

7632

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MM-12

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@]12(C(C(N3[C@](C(O[C@](/C(=C/[C@H]4C[C@@H](OC)[C@H](CC4)Cl)/C)([C@@H]([C@H](CC([C@@H](/C=C(/C[C@@H](C[C@@H]([C@](O1)([H])[C@H](C[C@H]2C)OC)OC)C)\C)CC)=O)O)C)[H])=O)(CCCC3)[H])=O)=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pimecrolimus. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.